04:52 PM EDT, 04/18/2024 (MT Newswires) -- Jaume Pons, Director, President & Chief Scientific Officer, on April 16, 2024, sold 50,000 shares in Alx Oncology Holdings ( ALXO ) for $710,195. Following the Form 4 filing with the SEC, Pons has control over a total of 604,205 shares of the company, with 604,205 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1810182/000141588924011128/xslF345X03/form4-04182024_080417.xml